Cellex qSARS-CoV-2 IgG/IgM Cassette Rapid Antibody Test - For Professional Use Only (25 Test cassettes)

CELLEX is a US based company, and is the first company to get an approval from the EUA-FDA ( Food and Drug Administration - US) for a test of this kind due to its superior quality and accuracy in comparison to its competitors. With such certification, imports into countries becomes easier too and hence this product is being supplied to several countries in Europe, United states and more.

The Cellex qSARS-CoV-2 IgG/IgM Rapid Test is a lateral flow immunoassay intended for the qualitative detection and differentiation of IgM and IgG antibodies to SARS-CoV-2 in serum, plasma (EDTA, citrate) or venipuncture whole blood specimens from patients suspected of COVID-19 infection by a healthcare provider.

-Detection of IgM and IgG antibodies to COVID-19 in a single test

-Suitable for whole blood, serum and plasma samples

-No special facilities or equipment necessary

-No specialised training required

-CE Marked

-EUA-FDA Approved

-Results in 15 minutes

Each Kit Includes;

*25 Test cassettes

*1 Bottle of sample buffer

*25 Transfer pipettes

*Leaflet with instructions for use